Permeability Enhancement
Permeability Enhancement is a prodrug design strategy in which the parent drug’s molecular structure is transiently modified (typically via reversible promoieties) to increase its ability to traverse biological barriers such as epithelial or endothelial membranes, thereby improving its absorption and bioavailability.
1.7K
Publications
95.7K
Citations
7.1K
Authors
1.7K
Institutions
Publications per year
2017–2026
376
1.7K
1–5 of 1.7K
7.1K
16
h-index
14
h-index
13
h-index
12
h-index
12
h-index
1–5 of 7.1K
1.7K
University of Utah
Salt Lake City, United States
19 h-index
73 publications
4K citations
Shenyang Pharmaceutical University
Shenyang, China
19 h-index
154 publications
4.8K citations
Charles University
Prague, Czechia
16 h-index
98 publications
3.6K citations

Centre National de la Recherche Scientifique
Paris, France
16 h-index
43 publications
3.7K citations
Hebrew University of Jerusalem
Jerusalem, Israel
15 h-index
53 publications
4.1K citations
University of California, San Francisco
San Francisco, United States
15 h-index
37 publications
2.2K citations
Harvard University
Cambridge, United States
15 h-index
67 publications
18.5K citations
University of Kansas
Lawrence, United States
14 h-index
67 publications
2.2K citations
1–8 of 1.7K
114 publications · 5.4K citations
44
h-index
55 publications · 3.4K citations
35
h-index
57 publications · 3.3K citations
32
h-index
44 publications · 3K citations
31
h-index
Repository · 78 publications · 3.7K citations
28
h-index
1–5